Par-4 prevents breast cancer recurrence

被引：2

作者：

Hebbar, Nikhil ^{[1
]}

Shrestha-Bhattarai, Tripti ^{[1
]}

Rangnekar, Vivek M. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA

[2] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA

[3] Univ Kentucky, Dept Microbiol Immunol, Lexington, KY 40536 USA

[4] Univ Kentucky, Dept Mol Genet, Lexington, KY 40536 USA

[5] Univ Kentucky, LP Markey Canc Ctr, Lexington, KY USA

来源：

BREAST CANCER RESEARCH | 2013年 / 15卷 / 05期

基金：

美国国家卫生研究院;

关键词：

DOWN-REGULATION; APOPTOSIS; GENE;

D O I：

10.1186/bcr3562

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Therapy resistance and disease recurrence are two of the most challenging aspects in breast cancer treatment. A recent article in Cancer Cell makes a significant contribution toward a better understanding of this therapeutic problem by establishing downregulation of the tumor suppressor Par-4 as the primary determinant of breast cancer recurrence. This viewpoint brings forth the importance of their findings and its implications on future research and therapy.

引用

页数：2

共 50 条

[41] The Par-4/PTEN connection in tumor suppression
Diaz-Meco, Maria T.
Abu-Baker, Shadi
CELL CYCLE, 2009, 8 (16) : 2518 - 2522
[42] Post-translational mechanisms related to PAR-4 regulation in endometrial cancer
Brasseur, Kevin
Parent, Sophie
Fabi, FranCois
Asselin, Eric
CANCER RESEARCH, 2014, 74 (19)
[43] Apoptosis and tumor resistance conferred by Par-4
Zhao, Yanming
Rangnekar, Vivek M.
CANCER BIOLOGY & THERAPY, 2008, 7 (12) : 1867 - 1874
[44] Mechanisms of apoptosis by the tumor suppressor Par-4
Hebbar, Nikhil
Wang, Chi
Rangnekar, Vivek M.
JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (12) : 3715 - 3721
[45] Par-4 links dopamine signaling and depression
Park, SK
Nguyen, MD
Fischer, A
Luke, MPS
Affar, EB
Dieffenbach, PB
Tseng, HC
Shi, Y
Tsai, LH
CELL, 2005, 122 (02) : 275 - 287
[46] Par(-4)oxysm in Breast Cancer
Shrestha-Bhattarai, Tripti
Hebbar, Nikhil
Rangnekar, Vivek M.
CANCER CELL, 2013, 24 (01) : 3 - 5
[47] PAR-4: A Novel Marker of Luminal A Breast Cancer is Down-Regulated by SRC-1 and HOXC11
Cahalin, A.
Bolger, J. C.
Walsh, C. A.
McCartan, D.
McIlroy, M.
Hill, A. D. K.
Young, L. S.
IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S162 - S162
[48] Par-4, an early and essential effector of neuronal apoptosis
Guo, Q
Mattson, MP
JOURNAL OF NEUROCHEMISTRY, 1999, 72 : S49 - S49
[49] Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose PAR-4 in cardiac fibroblasts
Kleeschulte, Sonja
Jerrentrup, Johann
Gorski, Daniel
Schmitt, Joachim
Fender, Anke C.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 252 : 163 - 166
[50] Fbxo45 joins the ‘Par-4’ty in controlling apoptosis of cancer cells
Z Wang
W Wei
Cell Death & Differentiation, 2014, 21 : 1508 - 1510

← 1 2 3 4 5 →